BCIQ Profiles

Company Profile Report

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

Fusion, PolyPid join the gene therapy company on NASDAQ, Hyloris prices IPO on Euronext

Among a trio of companies making their NASDAQ debuts on Friday, Akouos’ first-day rise of 29% was the biggest, while Fusion gave back its early gains and PolyPid also climbed in the aftermarket.

Across the Atlantic, Belgian drug reformulation company Hyloris Pharmaceuticals S.A.

Read the full 426 word article

How to gain access

Continue reading with a
two-week free trial.